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Alfonso Ielasi, MD,* Bernardo Cortese, MD,y Giuseppe SteffeninozA 49-year-old man underwent emergentcoronary angiography because of inferiorST-segment elevation myocardial infarction
(STEMI). It showed thrombotic occlusion of the prox-
imal posterior descending artery (PDA) of the right
coronary artery (RCA). The PDA was treated withFIGURE 1 BVS Structural Discontinuity at the Thrombotic Site
(A,B) A patent bare-metal stent in the posterior descending artery (PDA
segment of the right coronary artery (RCA). (C) Final result after implan
(D) In-scaffold thrombosis 19 months after implantation. Optical cohere
struts (E), residual intraluminal thrombus (F), and isolated scaffold stru
lumen (G,H) (Online Video 1).
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scaffolds (BVS Absorb [Abbott Vascular, Santa Clara,
California] 3.5  12 mm and 3.5  28 mm) were elec-
tively implanted 6 days later in the distal and mid
RCA (Figures 1A to 1C). Both BVS scaffolds were
post-dilated with a 3.75-mm noncompliant balloon.) (dotted parallel lines) and severe stenosis in the distal and mid
tation of 2 bioresorbable scaffolds in the mid and distal RCA.
nce tomography shows diffuse neointimal coverage of the scaffold
ts, with some embedded in tissue, protruding within the vessel
theterization Laboratory, Fatebenefratelli Hospital,
spital, Cuneo, Italy. The authors have reported that
.
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e172The patient was discharged on dual-antiplatelet
therapy (DAT) (acetylsalicylic acid and clopidogrel).
After 19 months of being well (7 months after clopi-
dogrel discontinuation), the patient experienced a
new inferior STEMI. The angiogram revealed BVS
thrombosis in the mid RCA (Figure 1D). After manual
thrombectomy and abciximab administration with
ST-resolution, optical coherence tomography (OCT)
showed partial resorption of BVS struts, diffuse
BVS neointimal coverage (Figure 1E), residual
intraluminal thrombus (Figure 1F), and isolated
intraluminal struts, some embedded in tissue, dis-
connected from the expected BVS circularity
(Figures 1G and 1H, Online Video 1). A 33-mm
everolimus-eluting metal stent was implanted in-
side the BVS.Although both early and mid-term BVS thrombosis
have been described and mostly related to technical
issues, acute BVS disruption during the index proce-
dure or premature DAT discontinuation (1), little is
known on very late BVS thrombosis. Benign “late
structural discontinuity” has been described by serial
OCT (2). Here we show the ﬁrst case of very late BVS
thrombosis, possibly triggered by structural discon-
tinuity during scaffold dismantling. This ﬁnding may
raise concerns about optimal DAT duration after BVS
implantation.
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